Pantoprazole Teva Italia (Pantoprazole Sodium)

Pantoprazole, the active ingredient in Pantoprazole Teva Italia, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat gastro‑reflux disease and related conditions in adults.

GNH USA supplies Pantoprazole Teva Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the acid‑secretion pathway of the stomach. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates mucosal healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the disorder.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): difficulty breathing, swelling of face or throat. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatitis. - Acute interstitial nephritis: kidney inflammation.

When prescribing Pantoprazole, clinicians should consider several safety aspects. - Renal impairment: adjust monitoring if kidney function is reduced. - Hepatic impairment: use with caution in patients with liver disease. - Long‑term therapy: evaluate need periodically to avoid unnecessary exposure. - Concomitant use of bisphosphonates or iron supplements: separate dosing times to improve absorption. - Pregnancy and lactation: prescribe only if benefit outweighs potential risk. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole may affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption due to higher gastric pH. - Atazanavir: markedly decreased antiviral exposure, risking treatment failure.

Moderate Interactions (Monitor Closely): - Clopidogrel: diminished antiplatelet effect, may require alternative therapy. - Warfarin: potential increase in INR, necessitating closer coagulation monitoring. - Methotrexate: higher systemic levels, especially with high‑dose regimens. - Digoxin: modest rise in serum concentration, monitor for toxicity.